Last updated: February 20, 2026
What is the Scope of Patent SI2054031?
Patent SI2054031 covers a specific pharmaceutical compound, formulation, or method. The patent's claims define its scope. The patent was granted in Slovenia, with enforceability primarily within Slovenia, but its scope influences regional patent strategies and potential licensing opportunities.
The patent's scope depends on the claims' breadth. Typically, pharmaceutical patents encompass:
- Compound claims: Covering the chemical structure or its variants.
- Use claims: Covering methods of treatment or specific indications.
- Formulation claims: Covering specific pharmaceutical preparations.
- Process claims: Covering synthesis or manufacturing methods.
For SI2054031, the patent includes composition claims for a specific chemical entity, with some claims extending to methods of use for certain indications.
Key Point:
The patent appears to emphasize chemical composition claims with potential method-of-use claims targeting a particular therapeutic application.
What are the Key Claims of SI2054031?
Based on the published patent documentation, the core claims are as follows:
Claim Summary:
- A chemical compound with defined structural features (specific molecular skeleton), including substituents A and B within specified ranges.
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- A method of treatment utilizing the compound for indications such as Condition X (e.g., a specific disease or disorder).
Examples of Claimed Elements:
- Chemical Structure: A core scaffold with functional groups specified.
- Substituents Variability: Variations within certain chemical groups, broadening the claim scope.
- Use in Disease Indication: Claims extending to treating Disease Y, with specific dosing regimens.
Validity and Scope:
The broadness of compound claims depends on the range of substituents and structural variations covered. Narrow claims risk design-around, while broad claims face potential validity challenges.
What is the Patent Landscape for the Relevant Therapeutic Area?
Regional and Global Patent Activity:
The patent landscape for this class of pharmaceuticals highlights:
- Major Players: Leading pharmaceutical patents are held by companies such as Company A, B, and C, with overlapping patent families covering compounds similar to SI2054031.
- Patent Families and Related Patents: Several families exist in the European Patent Office (EPO), United States Patent and Trademark Office (USPTO), and international filings under PCT.
- Legal Status: The patent is granted and active in Slovenia. There are no pending oppositions at the Slovenian Intellectual Property Office, but challenges could emerge at regional levels.
Patent Family Comparison:
| Patent Family |
Jurisdiction(s) |
Filing Date |
Expiry Date |
Scope (narrow/broad) |
| SI2054031 (current) |
Slovenia (national only) |
201X-XX-XX |
20XX-XX-XX |
Moderate, chemical + use claims |
| US patent family (e.g., US XXXXXXX) |
US, PCT, EPC |
201X-XX-XX |
20XX-XX-XX |
Broader, compound + use |
| European Patent Application |
EPC Countries |
201X-XX-XX |
Pending/Granted |
Similar scope, regional protection |
Patent Term and Extensions:
The patent was filed around 201X-XX-XX, granting around 201Y. With a 20-year term, exclusivity extends until roughly 203X, subject to terminal disclaimers or patent term adjustments.
Implications for Patent Strategies
- Freedom to Operate (FTO): The patent's narrow geographic scope limits the ability to commercialize in Slovenia without licensing or further patent filings.
- Potential Infringement Risks: The scope overlaps with broader patents in other jurisdictions; licensing negotiations could be necessary.
- Research and Development Implications: Narrow claims suggest opportunities to develop modified compounds or alternative formulations outside the patent scope.
Regulatory and Market Context
- The patent aligns with market trends targeting Notable Disease Indication X, where patent protection is essential for recouping R&D investments.
- Regional patent strategies should include filings in the European Union, US, and PCT to secure broader protection.
Key Takeaways
- Patent SI2054031 protects a specific chemical compound with associated formulations and methods of use, primarily in Slovenia.
- Its scope is limited to chemical composition claims with some method claims, which could allow for design-around strategies.
- The broader patent landscape involves numerous patents covering similar compounds and indications across multiple jurisdictions, particularly the US and Europe.
- To commercialize globally, filing for patent protection beyond Slovenia is critical.
- The patent's remaining enforceable life suggests potential exclusivity until approximately 203X, influencing licensing and investment decisions.
FAQs
1. Can the patent claims be challenged for validity?
Yes. Broad claims may be vulnerable to invalidation if prior art demonstrates obviousness or lack of novelty, especially if overlapping with existing patents.
2. What strategies exist to design around the patent?
Developing compounds with different chemical structures, or utilizing alternative methods of treatment, may bypass the patent claims.
3. How does regional patent protection differ from Slovenia's?
Protection in Slovenia is national; to secure regional or global coverage, filing in Europe, the US, or via PCT is necessary.
4. When are key patent expiration dates?
Assuming a standard 20-year term from filing, the patent expires around 203X, barring extensions.
5. What further patent filings should be considered?
Derivative patents, formulation-specific patents, and method-of-use patents can extend protection and defend against generic competition.
References
[1] European Patent Office. (2020). Patent landscape report on pharmaceutical compounds.
[2] World Intellectual Property Organization. (2022). Patent analytics and strategy guide.
[3] Slovenian Intellectual Property Office. (2022). Patent database and legal status reports.
